Cargando…

Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study

Background: In light of overlapping symptoms, discrimination between non-ST-elevation (NSTE) acute coronary syndrome (ACS) and acute heart failure (HF) is challenging, particularly in patients with equivocal clinical presentation for suspected ACS. We sought to evaluate the diagnostic and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: von Haehling, Stephan, Müller-Hennessen, Matthias, Garfias-Veitl, Tania, Goßling, Alina, Neumann, Johannes T., Sörensen, Nils A., Haller, Paul M., Hartikainen, Tau, Vollert, Jörn Ole, Möckel, Martin, Blankenberg, Stefan, Westermann, Dirk, Giannitsis, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092967/
https://www.ncbi.nlm.nih.gov/pubmed/37048135
http://dx.doi.org/10.3390/cells12071062
_version_ 1785023472008691712
author von Haehling, Stephan
Müller-Hennessen, Matthias
Garfias-Veitl, Tania
Goßling, Alina
Neumann, Johannes T.
Sörensen, Nils A.
Haller, Paul M.
Hartikainen, Tau
Vollert, Jörn Ole
Möckel, Martin
Blankenberg, Stefan
Westermann, Dirk
Giannitsis, Evangelos
author_facet von Haehling, Stephan
Müller-Hennessen, Matthias
Garfias-Veitl, Tania
Goßling, Alina
Neumann, Johannes T.
Sörensen, Nils A.
Haller, Paul M.
Hartikainen, Tau
Vollert, Jörn Ole
Möckel, Martin
Blankenberg, Stefan
Westermann, Dirk
Giannitsis, Evangelos
author_sort von Haehling, Stephan
collection PubMed
description Background: In light of overlapping symptoms, discrimination between non-ST-elevation (NSTE) acute coronary syndrome (ACS) and acute heart failure (HF) is challenging, particularly in patients with equivocal clinical presentation for suspected ACS. We sought to evaluate the diagnostic and prognostic properties of copeptin in this scenario. Methods: Data from 1088 patients from a single-center observational registry were used to test the ability of serial high sensitivity cardiac troponin T (hs-cTnT)—compared to copeptin, or a combination of copeptin with hs-cTnT—to discriminate acute HF from uncomplicated non-ST-elevation myocardial infarction (NSTEMI) and to evaluate all-cause mortality after 365 days. Patients with STEMI, those with unstable angina and either normal or undetectable hs-cTnT concentrations were excluded. The findings were validated in an independent external NSTE-ACS cohort. Results: A total of 219 patients were included in the analysis. The final diagnosis was acute HF in 56 and NSTE-ACS in 163, with NSTEMI in 78 and unstable angina having stable elevation of hs-cTnT >ULN in 85. The rate of all-cause death at 1 year was 9.6% and occurred significantly more often in acute HF than in NSTE-ACS (15 vs. 6%, p < 0.001). In the test cohort, the area under the receiver operator curve (AUC) for the discrimination of acute HF vs. NSTE-ACS without HF was 0.725 (95% confidence interval [CI] 0.625–0.798) for copeptin and significantly higher than for hs-cTnT at 0 h (AUC = 0.460, 0.370–0.550) or at 3 h (AUC = 0.441, 0.343–0.538). Copeptin and hs-cTnT used either as continuous values or at cutoffs optimized to yield 90% specificity for acute HF were associated with significantly higher age- and sex-adjusted risk for all-cause mortality at 365 days. The findings from the test cohort were consistently replicated in the independent external NSTE-ACS validation cohort. Conclusions: High concentrations of copeptin in patients with suspected NSTE-ACS and equivocal clinical presentation suggest the presence of acute HF compared to uncomplicated NSTE-ACS and are associated with higher rates of all-cause death at 365 days.
format Online
Article
Text
id pubmed-10092967
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100929672023-04-13 Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study von Haehling, Stephan Müller-Hennessen, Matthias Garfias-Veitl, Tania Goßling, Alina Neumann, Johannes T. Sörensen, Nils A. Haller, Paul M. Hartikainen, Tau Vollert, Jörn Ole Möckel, Martin Blankenberg, Stefan Westermann, Dirk Giannitsis, Evangelos Cells Article Background: In light of overlapping symptoms, discrimination between non-ST-elevation (NSTE) acute coronary syndrome (ACS) and acute heart failure (HF) is challenging, particularly in patients with equivocal clinical presentation for suspected ACS. We sought to evaluate the diagnostic and prognostic properties of copeptin in this scenario. Methods: Data from 1088 patients from a single-center observational registry were used to test the ability of serial high sensitivity cardiac troponin T (hs-cTnT)—compared to copeptin, or a combination of copeptin with hs-cTnT—to discriminate acute HF from uncomplicated non-ST-elevation myocardial infarction (NSTEMI) and to evaluate all-cause mortality after 365 days. Patients with STEMI, those with unstable angina and either normal or undetectable hs-cTnT concentrations were excluded. The findings were validated in an independent external NSTE-ACS cohort. Results: A total of 219 patients were included in the analysis. The final diagnosis was acute HF in 56 and NSTE-ACS in 163, with NSTEMI in 78 and unstable angina having stable elevation of hs-cTnT >ULN in 85. The rate of all-cause death at 1 year was 9.6% and occurred significantly more often in acute HF than in NSTE-ACS (15 vs. 6%, p < 0.001). In the test cohort, the area under the receiver operator curve (AUC) for the discrimination of acute HF vs. NSTE-ACS without HF was 0.725 (95% confidence interval [CI] 0.625–0.798) for copeptin and significantly higher than for hs-cTnT at 0 h (AUC = 0.460, 0.370–0.550) or at 3 h (AUC = 0.441, 0.343–0.538). Copeptin and hs-cTnT used either as continuous values or at cutoffs optimized to yield 90% specificity for acute HF were associated with significantly higher age- and sex-adjusted risk for all-cause mortality at 365 days. The findings from the test cohort were consistently replicated in the independent external NSTE-ACS validation cohort. Conclusions: High concentrations of copeptin in patients with suspected NSTE-ACS and equivocal clinical presentation suggest the presence of acute HF compared to uncomplicated NSTE-ACS and are associated with higher rates of all-cause death at 365 days. MDPI 2023-03-31 /pmc/articles/PMC10092967/ /pubmed/37048135 http://dx.doi.org/10.3390/cells12071062 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
von Haehling, Stephan
Müller-Hennessen, Matthias
Garfias-Veitl, Tania
Goßling, Alina
Neumann, Johannes T.
Sörensen, Nils A.
Haller, Paul M.
Hartikainen, Tau
Vollert, Jörn Ole
Möckel, Martin
Blankenberg, Stefan
Westermann, Dirk
Giannitsis, Evangelos
Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study
title Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study
title_full Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study
title_fullStr Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study
title_full_unstemmed Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study
title_short Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study
title_sort role of copeptin and hs-ctnt to discriminate ahf from uncomplicated nste-acs with baseline elevated hs-ctnt—a derivation and external validation study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092967/
https://www.ncbi.nlm.nih.gov/pubmed/37048135
http://dx.doi.org/10.3390/cells12071062
work_keys_str_mv AT vonhaehlingstephan roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT mullerhennessenmatthias roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT garfiasveitltania roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT goßlingalina roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT neumannjohannest roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT sorensennilsa roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT hallerpaulm roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT hartikainentau roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT vollertjornole roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT mockelmartin roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT blankenbergstefan roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT westermanndirk roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy
AT giannitsisevangelos roleofcopeptinandhsctnttodiscriminateahffromuncomplicatednsteacswithbaselineelevatedhsctntaderivationandexternalvalidationstudy